Integrin Signaling Pathway In Neurodegeneration represents a key pathological mechanism in neurodegenerative diseases. This page explores the molecular and cellular processes involved, their contribution to disease progression, and therapeutic implications.
The Integrin Signaling Pathway comprises a family of cell surface receptors that mediate cell-matrix and cell-cell adhesion, playing critical roles in neuronal survival, migration, synaptic plasticity, and axon guidance. Dysregulation of integrin signaling is increasingly recognized as a key contributor to neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and Huntington's disease (HD).
Integrins are heterodimeric transmembrane proteins consisting of α and β subunits. In the nervous system, key integrins include:
Integrins transduce signals through two primary mechanisms:
Focal adhesion kinase (FAK) is a central integrator of integrin signaling:
ECM (Fibronectin/Laminin)
↓
Integrin α/β heterodimer
↓
FAK autophosphorylation (Y397)
↓
Src family kinases activation
↓
PI3K/AKT survival pathway
↓
mTOR/GSK3β signaling
FAK activation leads to:
The ILK complex connects integrins to cytoskeletal dynamics:
This complex regulates:
Integrin engagement activates the MAPK pathway:
Integrin dysfunction contributes to multiple AD hallmarks:
Amyloid-β Interaction
** tau Pathology**
Synaptic Failure
α-Synuclein Interaction
Mitochondrial Function
Neuromuscular Junction
Astrocyte-Neuron Communication
| Target | Approach | Status |
|---|---|---|
| FAK inhibitors | Neuroprotection | Preclinical |
| Integrin agonists | Synaptic maintenance | Research |
| ILK inhibitors | Modulate tau | Experimental |
| α5β1 antagonists | Reduce Aβ toxicity | Investigational |
The study of Integrin Signaling Pathway In Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Pinke, K.H., et al. (2015). The role of integrins in the pathogenesis of Alzheimer's disease. J. Alzheimer's Dis., 45(2): 331-345.
Wu, X., & Reddy, D.S. (2012). Integrins as receptor subtypes for primitive neuroectodermal tumor invasion. Cell Adh. Migr., 6(1): 71-79.
Galli, C., et al. (2015). Integrins and alpha-synuclein: A pathological link in Parkinson's disease? Neurobiol. Aging, 36(2): 725-734.
Islam, M., & Zhang, C.L. (2015). Integrins in the development and pathology of the nervous system. Cell Stem Cell, 16(5): 452-454.
McGough, I.J., et al. (2017). Axon guidance: Integrins give the signal. Curr. Biol., 27(2): R58-R60.
Palavalli, L.H., et al. (2021). Targeting integrin signaling in neurodegenerative diseases. Neurotherapeutics, 18(2): 782-800.
Zhao, Y., et al. (2020). Integrin-linked kinase: A potential therapeutic target for neurodegenerative diseases. Ageing Res. Rev., 62: 101098.
Chan, C.S., et al. (2017). Fyn signaling in neurodegenerative diseases. J. Neurochem., 142(2): 170-188.
Cuesto, G., et al. (2015). Phosphoinositide-3-kinase activation controls synaptic function and memory. J. Neurosci., 35(40): 14019-14033.
Calderone, D., et al. (2022). Integrin-mediated remodeling of the neuronal synapse in health and disease. Nat. Rev. Neurosci., 23(4): 217-232.
🔴 Low Confidence
| Dimension | Score |
|---|---|
| Supporting Studies | 10 references |
| Replication | 0% |
| Effect Sizes | 25% |
| Contradicting Evidence | 0% |
| Mechanistic Completeness | 50% |
Overall Confidence: 31%